Robert Briddell
Impact in
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation
- Platelet Disorders and Treatments
- Genetics top 5%
- Mesenchymal stem cell research
Papers in
- Hematology 27
- Hematopoietic Stem Cell Transplantation 16
- Platelet Disorders and Treatments 12
- Chronic Myeloid Leukemia Treatments 4
- Blood groups and transfusion 3
-
- Glycosylation and Glycoproteins Research 5
- Co-authors
- Ian McNiece (8 shared papers)J Brandt (8 shared papers)Robert S. Hoffman (7 shared papers)E Bruno (7 shared papers)Koen van Besien (5 shared papers)Ryan Cooper (4 shared papers)Edward F. Srour (3 shared papers)Ronald Hoffman (3 shared papers)
- Journals
- Blood (5 papers)Stem Cells (5 papers)Journal of Clinical Investigation (3 papers)Experimental Hematology (2 papers)New England Journal of Medicine (2 papers)
- Partner nations
- United StatesBelgiumUnited Kingdom
In The Last Decade
Robert Briddell
37 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 87
- Hematology 873
- Genetics 293
- Immunology 482
- Oncology 302
- Dermatology 79
Countries citing papers authored by Robert Briddell
This map shows the geographic impact of Robert Briddell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Briddell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Briddell more than expected).
Fields of papers citing papers by Robert Briddell
This network shows the impact of papers produced by Robert Briddell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Briddell. The network helps show where Robert Briddell may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Briddell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 147 | |
| 2 | Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties. | 2003 | 142 |
| 3 | 1990 | 124 | |
| 4 | 1997 | 124 | |
| 5 | Effects of recombinant interleukin 11 on human megakaryocyte progenitor cells. | 1991 | 124 |
| 6 | Effect of recombinant and purified hematopoietic growth factors on human megakaryocyte colony formation. | 1988 | 112 |
| 7 | Human CD34+ HLA-DR- bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesis. | 1991 | 110 |
| 8 | 2006 | 94 | |
| 9 | 1987 | 78 | |
| 10 | 1995 | 70 | |
| 11 | 2015 | 64 | |
| 12 | 2001 | 58 | |
| 13 | 1997 | 53 | |
| 14 | 1988 | 53 | |
| 15 | 1994 | 52 | |
| 16 | 1987 | 47 | |
| 17 | 1989 | 37 | |
| 18 | 2000 | 31 | |
| 19 | 1996 | 25 | |
| 20 | 1999 | 23 |
About Robert Briddell
Robert Briddell is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Genetics, having authored 38 papers that have together received 1.7k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (16 papers), Platelet Disorders and Treatments (12 papers), Glycosylation and Glycoproteins Research (5 papers), Mesenchymal stem cell research (5 papers), Cancer Cells and Metastasis (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Virus-based gene therapy research (4 papers) and Blood groups and transfusion (3 papers). The work is most often cited by research in Hematology (873 citations), Genetics (293 citations), Immunology (482 citations), Oncology (302 citations) and Dermatology (79 citations). Robert Briddell has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Ian McNiece, J Brandt, Robert S. Hoffman, E Bruno, Koen van Besien, Ryan Cooper, Edward F. Srour, Ronald Hoffman, E Bruno and IK McNiece. Their work appears in journals such as Blood, Stem Cells, Journal of Clinical Investigation, Experimental Hematology and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.